ATE118784T1 - Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen. - Google Patents

Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen.

Info

Publication number
ATE118784T1
ATE118784T1 AT86904585T AT86904585T ATE118784T1 AT E118784 T1 ATE118784 T1 AT E118784T1 AT 86904585 T AT86904585 T AT 86904585T AT 86904585 T AT86904585 T AT 86904585T AT E118784 T1 ATE118784 T1 AT E118784T1
Authority
AT
Austria
Prior art keywords
pct
plasmodium vivax
circumsporozoite protein
peptide antigen
immunogenic peptide
Prior art date
Application number
AT86904585T
Other languages
English (en)
Inventor
David E Arnot
Vincenzo Enea
Ruth S Nussenzweig
Victor N Nussenzweig
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Application granted granted Critical
Publication of ATE118784T1 publication Critical patent/ATE118784T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT86904585T 1985-07-12 1986-06-24 Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen. ATE118784T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75464585A 1985-07-12 1985-07-12

Publications (1)

Publication Number Publication Date
ATE118784T1 true ATE118784T1 (de) 1995-03-15

Family

ID=25035714

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86904585T ATE118784T1 (de) 1985-07-12 1986-06-24 Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen.

Country Status (13)

Country Link
US (1) US5700906A (de)
EP (1) EP0229829B1 (de)
JP (1) JPS63500591A (de)
AT (1) ATE118784T1 (de)
AU (1) AU590599B2 (de)
DE (1) DE3650242T2 (de)
DK (1) DK124087A (de)
ES (2) ES2002467A6 (de)
IL (1) IL79277A0 (de)
NZ (1) NZ216823A (de)
PT (1) PT82975B (de)
WO (1) WO1987000533A1 (de)
ZA (1) ZA865235B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it
IT1226711B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Antigeni sintetici utili per la diagnosi della malaria da plasmodium vivax.
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
US6333406B1 (en) 1988-08-12 2001-12-25 Joseph W. Inselburg Gene encoding protein antigens of Plasmodium falciparum and uses therefor
SE8904100D0 (sv) * 1989-12-05 1989-12-05 Astra Ab New analysis method
NZ233255A (en) * 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
AU5649290A (en) * 1989-04-12 1990-11-05 New York University Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
WO1993011157A1 (en) * 1991-11-27 1993-06-10 The Council Of The Queensland Institute Of Medical Research MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX)
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
BR0016472A (pt) * 1999-12-17 2002-08-20 Cápsula de ignição indutivamente ativável para sistemas de retenção de ocupantes de assento
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
US20040176283A1 (en) * 2002-04-01 2004-09-09 Robinson John A. Methods and compositions for the design of synthetic vaccines
CA2520865A1 (en) * 2003-03-31 2004-10-21 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
TWI309240B (en) 2004-09-17 2009-05-01 Hoffmann La Roche Anti-ox40l antibodies
US7749519B2 (en) * 2005-12-09 2010-07-06 Kim Lee Sim Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax
US8206726B2 (en) 2006-02-06 2012-06-26 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
CA2657279A1 (en) * 2006-07-18 2008-01-24 Glaxosmithkline Biologicals S.A. Vaccines for malaria
EP2731617A4 (de) 2011-07-12 2015-07-01 Brigham & Womens Hospital Lipidhaltige psa-zusammensetzungen, verfahren zu ihrer isolierung und verwendungsverfahren dafür
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
US20140272993A1 (en) * 2013-03-15 2014-09-18 The Translational Genomics Research Institute Method of sequencing a full microrna profile from cerebrospinal fluid
EP3337321A4 (de) 2015-08-19 2019-07-17 President and Fellows of Harvard College Lipidierte psa-zusammensetzungen und verfahren
EP3484441A4 (de) 2016-07-15 2020-03-18 President and Fellows of Harvard College Glycolipidzusammensetzungen und verfahren zur verwendung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
US4559602A (en) * 1983-01-27 1985-12-17 Bates Jr John K Signal processing and synthesizing method and apparatus
US4769235A (en) * 1984-01-27 1988-09-06 New York University Immunodominant epitope of the circumsporozoite surface protein
EP0153188B1 (de) * 1984-02-21 1991-10-09 National Research Development Corporation Herstellung von Malaria-Impfstoffen
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
NZ213303A (en) * 1984-09-12 1988-09-29 Univ New York Plasmodium protein, dna sequence and vaccine
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene

Also Published As

Publication number Publication date
PT82975B (pt) 1988-07-01
ZA865235B (en) 1987-03-25
ES2006631A6 (es) 1989-05-01
AU590599B2 (en) 1989-11-09
EP0229829A4 (de) 1988-07-27
DE3650242D1 (de) 1995-03-30
NZ216823A (en) 1990-12-21
US5700906A (en) 1997-12-23
AU6129286A (en) 1987-02-10
PT82975A (en) 1986-08-01
WO1987000533A1 (en) 1987-01-29
EP0229829B1 (de) 1995-02-22
DE3650242T2 (de) 1995-06-14
IL79277A0 (en) 1986-09-30
DK124087D0 (da) 1987-03-11
EP0229829A1 (de) 1987-07-29
ES2002467A6 (es) 1988-08-16
JPS63500591A (ja) 1988-03-03
DK124087A (da) 1987-03-11

Similar Documents

Publication Publication Date Title
ATE118784T1 (de) Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen.
Sinigaglia et al. Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein
CA2329772A1 (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
DK0839196T3 (da) Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
GB2143830A (en) Expression of plasmodium falciparum polypeptides from cloned cdna
IL75788A (en) Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein
DE3883439D1 (de) Bestimmung von Peptidsequenzen.
IE860846L (en) Immunogenic antigen-carrier protein conjugate for use in a¹vaccine against malaria
DE3879968D1 (de) Malaria-impfstoff aus copolymerem protein.
NZ234049A (en) Peptide epitopes of, and antibodies to htlv-1
ATE159172T1 (de) Peptide und deren verwendung
ES2006730A6 (es) Un metodo de preparar un peptido o polipeptido sintetico que presenta la antigenicidad de la totalidad o una parte de un antigeno de p. falciparum
NZ213303A (en) Plasmodium protein, dna sequence and vaccine
DE69018325D1 (de) Antigen-Protein der Sporozoit- und hepatischen Phase von P. falciparum.
MY104081A (en) Rhoptry membrane antigen of plasmodium falciparum.
EP0320034A3 (de) Synthetische Peptide, die immunologische Aktivität zeigen, benutzbar, um eine Impfung gegen Malaria vorzubereiten
AU7163091A (en) Novel malarial sporozoite peptide antigens
DE3876227D1 (de) Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung.
IL83231A0 (en) Small molecular weight antigen of plasmodium falciparum,antibodies directed thereto,purification and detection of said antigen
SE8702698L (sv) Polypeptid, anvendbar for framstellning av antimalariavacciner och diagnostest for pavisande av malariasjukdomar
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
TH4338A (th) พลาสโมเดียม ฟาลซิพารุมที่ไร้เพศระยะซึ่งอยู่ในเลือด
IT8622272A0 (it) Metodo per l'identificazione immediata da colture di salmonella e preparazione del reattivo impiegato.